Australia · Series B startup

Who invested in Kinoxis Therapeutics

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 1 month ago

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2024, from 2 sources

$9.5MSeries B$4.8MRound
Latest round
Round, $4.8MSept 2026
Led by
Main Sequence Ventures
Biggest round
$9.5MSeries B · Aug 2024
Investors
4 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026
$9.5MSeries B$4.8MRound
First round
Series B, $9.5M
Aug 2024
Biggest round
$9.5M
Series B · Aug 2024
Between rounds
2.2 years
from the last two

The rounds

  1. Sept 2026
    Round$4.8M1 new2 returning

    Reported by Startup Daily

  2. Aug 2024

Founders and team

From Kinoxis Therapeutics's own website: 2 founders, 9 on the team.

Hugh AlsopChief Executive Officer, Co-Founder
Michael BowenChief Scientific Officer, Co-Founder
  • Tiina AhveninenVice President, Clinical Research
  • Tristan ReekieVice President, Discovery Research
  • Cameron JonesCFO & Company Secretary
  • Brooke RaphaelNon-Executive Director
  • Dr Elaine SteadNon-Executive Director
  • Dr John KurekNon-Executive Director
  • Dr Kathy NielsenNon-Executive Director
  • Dr Peter DevineChair
  • Prof. Julie CairneyNon-Executive Director

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

iSeedVC firm2rounds
Uniseed VenturesVC firm2rounds
Main Sequence VenturesVC firm1round, led 1

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Kinoxis Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Stoic Venture CapitalVC firmPer its own site

Quick answers about Kinoxis Therapeutics

Who invested in Kinoxis Therapeutics?

Kinoxis Therapeutics's investors include iSeed, Uniseed Ventures, Main Sequence Ventures and National Institutes of Health. Main Sequence Ventures led its latest round.

How much has Kinoxis Therapeutics raised?

Kinoxis Therapeutics has raised $14M across 2 rounds since 2024.

When did Kinoxis Therapeutics last raise?

Kinoxis Therapeutics's most recent round, $4.8M, was in Sept 2026, led by Main Sequence Ventures.

What was Kinoxis Therapeutics's biggest round?

Kinoxis Therapeutics's largest round on record is $9.5M (Series B), in Aug 2024.

Who backed Kinoxis Therapeutics first?

Kinoxis Therapeutics's first round on record, in Aug 2024, was backed by National Institutes of Health, iSeed and Uniseed Ventures.

What stage is Kinoxis Therapeutics at?

Kinoxis Therapeutics's latest named round is a Series B, in Aug 2024.

Where is Kinoxis Therapeutics based?

Kinoxis Therapeutics is based in Australia.

Who led Kinoxis Therapeutics's rounds?

Main Sequence Ventures led the funding round in 2026.

Companies like Kinoxis Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.